JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, cilt.10, sa.1, ss.79-81, 1997 (SCI-Expanded)
Long-term diazoxide and somatostatin analogue have been used in the treatment of persistent hyperinsulinemic hypoglycemia of infancy albeit with some side effects, We report a ease with persistent hyperinsulinemic hypoglycemia who has been on diazoxide therapy for 4.5 years. Diazoxide treatment maintained normoglycemia without causing any side effects, including hypertrichosis.